Donna Ambrosino
Directeur/Bestuurslid bij CLOVER BIOPHARMACEUTICALS, LTD.
Vermogen: 7 039 $ op 30-04-2024
Actieve functies van Donna Ambrosino
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| CLOVER BIOPHARMACEUTICALS, LTD. | Directeur/Bestuurslid | 17-06-2022 | - |
Loopbaan van Donna Ambrosino
Eerdere bekende functies van Donna Ambrosino
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| VISTERRA INC | Hoofd Techniek/Wetenschap/O&O | 01-01-2012 | 01-01-2014 |
| Harvard Medical School | Corporate Officer/Principal | - | - |
Opleiding van Donna Ambrosino
| Dartmouth Medical School | Doctorate Degree |
| Harvard University | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
| China | 2 |
Operationeel
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Sectoraal
| Consumer Services | 4 |
| Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CLOVER BIOPHARMACEUTICALS, LTD. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Visterra, Inc.
 Visterra, Inc. Pharmaceuticals: MajorHealth Technology Visterra, Inc. Is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of antibody-based therapies for kidney diseases, and other chronic diseases. It focuses on its research technology platform, HIEROTOPE technology. The company was founded by Alan L. Crane, Kevin J. Bitterman and Ram Sasisekharan on December 20, 2007 and is headquartered in Waltham, MA. | Health Technology |
- Beurs
- Insiders
- Donna Ambrosino
- Ervaring
